XMSMGL9
Market cap3.59bUSD
Dec 20, Last price
13.40EUR
1D
0.22%
1Q
-14.65%
Jan 2017
-15.08%
Name
Glanbia PLC
Chart & Performance
Profile
Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 5,425,400 -3.85% | 5,642,400 34.44% | 4,196,900 9.78% | |||||||
Cost of revenue | 4,956,200 | 5,348,613 | 4,002,600 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 469,200 | 293,787 | 194,300 | |||||||
NOPBT Margin | 8.65% | 5.21% | 4.63% | |||||||
Operating Taxes | 44,700 | 25,700 | 17,000 | |||||||
Tax Rate | 9.53% | 8.75% | 8.75% | |||||||
NOPAT | 424,500 | 268,087 | 177,300 | |||||||
Net income | 311,958 56.29% | 199,600 5.56% | 189,081 8.35% | |||||||
Dividends | (97,200) | (88,900) | ||||||||
Dividend yield | 2.41% | 2.54% | ||||||||
Proceeds from repurchase of equity | (148,100) | (196,900) | (93,800) | |||||||
BB yield | 3.68% | 5.62% | 2.60% | |||||||
Debt | ||||||||||
Debt current | 129,000 | 276,000 | 151,000 | |||||||
Long-term debt | 752,200 | 851,600 | 921,700 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 5,300 | 5,200 | 53,300 | |||||||
Net debt | 320,851 | 476,444 | 655,200 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 427,800 | 298,300 | 251,100 | |||||||
CAPEX | (74,200) | (68,900) | (77,500) | |||||||
Cash from investing activities | 84,000 | 176,700 | (147,300) | |||||||
Cash from financing activities | (358,969) | (390,200) | (118,300) | |||||||
FCF | 681,630 | 136,357 | (151,000) | |||||||
Balance | ||||||||||
Cash | 413,700 | 438,600 | 231,000 | |||||||
Long term investments | 146,649 | 212,556 | 186,500 | |||||||
Excess cash | 289,079 | 369,036 | 207,655 | |||||||
Stockholders' equity | 1,850,600 | 1,686,448 | 1,746,700 | |||||||
Invested Capital | 2,620,621 | 2,517,364 | 2,539,145 | |||||||
ROIC | 16.52% | 10.60% | 7.82% | |||||||
ROCE | 15.40% | 9.74% | 6.72% | |||||||
EV | ||||||||||
Common stock shares outstanding | 270,142 | 293,817 | 293,817 | |||||||
Price | 14.91 25.08% | 11.92 -3.09% | 12.30 18.50% | |||||||
Market cap | 4,027,818 15.00% | 3,502,299 -3.09% | 3,613,949 17.64% | |||||||
EV | 4,348,669 | 3,986,043 | 4,277,249 | |||||||
EBITDA | 618,200 | 436,287 | 321,200 | |||||||
EV/EBITDA | 7.03 | 9.14 | 13.32 | |||||||
Interest | 19,200 | 19,300 | 17,300 | |||||||
Interest/NOPBT | 4.09% | 6.57% | 8.90% |